Porque, no nos engaemos, el auge de los productos vinculados a anlogos de GLP-1 afecta a los usuarios de esta clase de frmacos, pero ms an a los que no se medican
See a dermatologist annually
Freezing is one way to halt this degradation, but it has significant drawbacksit can damage the molecule, for example, and it requires extensive cold chain logistics
Coverage unavailable when GLP-1 coverable under Part D benefit Beneficiaries who are prescribed Wegovy or Zepbound for a use that is coverable under the basic Medicare Part D benefit, regardless of whether the drug is on the Part D plans formulary (e.g., Zepbound for the treatment of moderate to severe obstructive sleep apnea in adults with obesity, or Wegovy to reduce the risk of major adverse cardiovascular (CV) events in adults with established CV disease who are either obese or overweight), will not qualify for coverage of that drug under the Bridge Program
The early observational signals have not held up under closer review